|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0021747,
umls-concept:C0030705,
umls-concept:C0035525,
umls-concept:C0205466,
umls-concept:C0220847,
umls-concept:C0521115,
umls-concept:C0871261,
umls-concept:C1521828,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C1963724,
umls-concept:C2911692
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2007-11-20
|
|
pubmed:abstractText |
To investigate whether concomitant antiretroviral therapy (ART) is a predictor of sustained virological response (SVR) in human immunodeficiency virus (HIV)/hepatitis C virus (HCV)-coinfected patients treated with pegylated interferon plus ribavirin.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-HIV Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha,
http://linkedlifedata.com/resource/pubmed/chemical/Polyethylene Glycols,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Viral,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Reverse Transcriptase Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Ribavirin,
http://linkedlifedata.com/resource/pubmed/chemical/interferon alfa-2a,
http://linkedlifedata.com/resource/pubmed/chemical/interferon alfa-2b,
http://linkedlifedata.com/resource/pubmed/chemical/peginterferon alfa-2a,
http://linkedlifedata.com/resource/pubmed/chemical/peginterferon alfa-2b
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0305-7453
|
|
pubmed:author |
pubmed-author:Carrillo-GómezRaquelR,
pubmed-author:ColladoAntonioA,
pubmed-author:Gómez-MateosJesúsJ,
pubmed-author:García-GarcíaJosé AJA,
pubmed-author:GilIgnacio de los SantosIde L,
pubmed-author:Girón-GonzálezJosé AJA,
pubmed-author:González-SerranoMercedesM,
pubmed-author:López-CortésLuis FLF,
pubmed-author:MerinoDoloresD,
pubmed-author:MiraJosé AJA,
pubmed-author:PinedaJuan AJA,
pubmed-author:Ríos-VillegasMaría JMJ,
pubmed-author:RiveroAntonioA,
pubmed-author:Valera-BestardBárbaraB
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
60
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1347-54
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:17938129-Adult,
pubmed-meshheading:17938129-Anti-HIV Agents,
pubmed-meshheading:17938129-Antiviral Agents,
pubmed-meshheading:17938129-Female,
pubmed-meshheading:17938129-HIV,
pubmed-meshheading:17938129-HIV Infections,
pubmed-meshheading:17938129-Hepacivirus,
pubmed-meshheading:17938129-Hepatitis C,
pubmed-meshheading:17938129-Humans,
pubmed-meshheading:17938129-Interferon-alpha,
pubmed-meshheading:17938129-Male,
pubmed-meshheading:17938129-Polyethylene Glycols,
pubmed-meshheading:17938129-RNA, Viral,
pubmed-meshheading:17938129-Recombinant Proteins,
pubmed-meshheading:17938129-Reverse Transcriptase Inhibitors,
pubmed-meshheading:17938129-Ribavirin,
pubmed-meshheading:17938129-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patients.
|
|
pubmed:affiliation |
Unidad de Enfermedades Infecciosas, Hospital Universitario de Valme, Sevilla, Spain. japineda@telefonica.net
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
